spacer
home > pmps > Winter 2012
PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

pmps
Winter 2012
   
Text
PDF
bullet
Manufacturing
New Manufacturing Challenges

Changing Lanes

New products mean new manufacturing systems, and as more complex products are created, drug production will have to adapt to the innovations coming from the development laboratories. Matthew Chandler at Sagentia Ltd shows manufacturers the way ahead.
 
view
download pdf
Prefilled Syringes: Filling Systems

The Future of Processing


Several market drivers are steering the prefilled syringe industry into new territory, requiring producers to step up their filling and closure systems, as Klaus Ullherr at Robert Bosch GmbH explains.
 
view
download pdf
Manufacturing Environment

Taking Care of Air


Air quality, humidity and temperature need to be monitored closely to ensure a stable manufacturing environment. Chris Hansford at Hansford Sensors presents guiding principles and technologies for maintaining air within required specifications.
 
view
download pdf
Prefilled Syringes: Quality by Design

Designed, Sealed and Delivered


A quality by design approach can render a syringe manufacturing facility that truly lives up to its potential and ensures a superior return on investment through an optimised plant structure, as Kay Schmidt at Catalent Pharma Solutions shows.
 
view
download pdf
Quality Control

Total Recall

In most cases, product recalls are disastrous, so manufacturers should pull out all stops to eliminate the possibility. This process can be assisted by suitable in-line testing and checks, as Todd Blonshine at Mustard Tree Instruments explains.
 
view
download pdf
bullet
Cool Chain, Cargo & Logistics
Clinical Trial Logistics: IT Systems

Chain Control

The march of technology will enhance management of the R&D supply chain and enable a clearer picture of product movement through superior IT solutions, as Dirk Machert and Jens Mattuschka at PAREXEL International present.
 
view
download pdf
The End of the Line

Is Bigger Better?

A packaging solution needs to be the best, rather than just the biggest, points out Richard Harrop.
 
view
download pdf
Spotlight: Cool Chain Association

The Ultimate Aim

The current initiatives of the Cool Chain Association promise to bring safer products into the supply chain and reduce the potential for waste.
 
view
download pdf
Air Cargo

Jet Set


How difficult is it to transport drugs by air? Christopher Dehio at Lufthansa Cargo AG explains why this method has a history of danger, and picks out the points in the process where temperaturesensitive cargo is most at risk.
 
view
download pdf
Transport Media

A Safe Platform

Jim Hardisty at Goplasticpallets.com
discusses physical risk in the logistics environment, and how devices such as pallets should be chosen carefully to ensure the safety of transport personnel.
 
view
download pdf
bullet
Drug Delivery 
Prefilled Syringes: Device Design

Style and Substance

To ensure patient safety and adherence, as well as create brand value, the design of a prefi lled syringe must be user-focused, and should encompass several guiding principles as part of the design concept, as Dan Formosa at Smart Design points out.

 
view
download pdf
bullet
Packaging, Packing & Anti-Counterfeiting
Global Packaging Strategies

Location, Location, Location


Streamlining the supply chain is the obvious option for companies looking to trim the fat from their distribution budget. But as Daniel Nott at Honeywell points out, they should also consider packaging technology itself, which can now provide protection for truly international conditions.
 
view
download pdf
Patient Information Leaflets

On the Same Page

Neil Gleghorn at Kallik highlights how patient information leafl ets are undergoing a transformation, and points to new EU readability guidelines that will require packagers to take a more proactive approach to keeping end-users informed.
 
view
download pdf
Primary Packaging

The Extractable Question

Michael Creese at Smithers Rapra
reviews the current trends in extractables and leachables testing, and makes several points of comparison between approaches in the pharmaceutical, food and medical device industries.
 
view
download pdf
Traceability: 21 CFR Part 11

Timed to Perfection

Electronic packaging systems that track products effectively are now a central element in the supply chain. Rob Dinsmore at SolutionsPT introduces the concept of ‘availability’, which can be incorporated into tracking systems in the form of hardware and software to eliminate costly errors.
 
view
download pdf
Radio-Frequency Identification

Riding the New Wave

As new technology and handheld devices continue their rise to dominance, Randy Stigall at UPM identifies the ways in which tracking pharmaceutical products can be made easier by buying into these new solutions, including near fi eld communication.
 
view
download pdf
bullet
Formulations, Ingredients and Excipients
API Manufacturing

Novel Dispensation

Howard Biddle at 42 Technology discusses the need for effective API dispensation for oral dosage, and shows how sticky web technology provides a simple yet precise option that is starting to be commercialised on a wider scale.
 
view
download pdf
   
spacer
Edited by
Dr Graham Hughes
Consultant in
Pharmaceutical
Development
Published quarterly in
February, May,
August and November

News and Press Releases

Global Medical Manufacturers Turn to Distributors to Tap the Eastern European Market

LONDON – 30 September 2014 – Established and new medical technology service providers are increasingly looking at distributors to help penetrate the growing Eastern European medical devices market. Distribution models eliminate the need for a sales team and regional/local offices, reducing the costs incurred by medical technology service providers. This is a crucial advantage as medical technology service providers are operating within a budget-constrained healthcare environment.
More info >>

White Papers

Analysis of Biopharmaceuticals to Conform to ICHQ6B

RSSL

Worldwide, the pharmaceuticals market is anticipated to grow from more than USD 782 billion in 2011 to approach a value of just over USD 971 billion by the end of 2016, registering a CAGR of over 24%. In 2010 the average medicines expenditure per person within the UK was £271, and this is expected to increase with the ageing population. A significant and increasing proportion of these sales are protein-based biotherapeutics or biomolecules. Currently, these account for 19% of the total market, and are growing at twice the rate of traditional small molecule pharmaceuticals. It is predicted that close to 50% of the top 100 pharmaceutical products will be biomolecules by 2016. By far the largest segment of the biopharmaceutical market is the monoclonal antibody (MAb) with an estimated share of 25.6%, which corresponds to USD 51.1 billion.
More info >>

Industry Events

Emballage – Manutention 2014

17-20 November 2014, Paris Nord Villepinte Exhibition Centre, Paris – France

From 17th to 20th November 2014, EMBALLAGE and MANUTENTION will come together with a comprehensive and complementary offer for worldwide professionals from 4 business sectors: PACKAGING – PROCESSING – PRINTING – HANDLING.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement